Gallagher KE - Search Results

1

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

Afolabi MO, Ishola D, Manno D, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Greenwood B, Leyssen M, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group. Afolabi MO, et al. Among authors: gallagher ke. Lancet Infect Dis. 2022 Jan;22(1):110-122. doi: 10.1016/S1473-3099(21)00128-6. Epub 2021 Sep 13. Lancet Infect Dis. 2022. PMID: 34529962 Free PMC article. Clinical Trial.

2

Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review.

Gallagher KE, Kadokura E, Eckert LO, Miyake S, Mounier-Jack S, Aldea M, Ross DA, Watson-Jones D. Gallagher KE, et al. BMC Public Health. 2016 Feb 19;16:172. doi: 10.1186/s12889-016-2845-z. BMC Public Health. 2016. PMID: 26895838 Free PMC article. Review.

3

The Association Between Cervical Human Papillomavirus Infection and Subsequent HIV Acquisition in Tanzanian and Ugandan Women: A Nested Case-Control Study.

Gallagher KE, Baisley K, Grosskurth H, Vallely A, Kapiga S, Vandepitte J, Kamali A, De Sanjosé S, Changalucha J, Hayes R, Watson-Jones D. Gallagher KE, et al. J Infect Dis. 2016 Jul 1;214(1):87-95. doi: 10.1093/infdis/jiw094. Epub 2016 Mar 6. J Infect Dis. 2016. PMID: 26951818 Free PMC article.

4

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries.

Howard N, Mounier-Jack S, Gallagher KE, Kabakama S, Griffiths UK, Feletto M, LaMontagne DS, Burchett HE, Watson-Jones D. Howard N, et al. Among authors: gallagher ke. Hum Vaccin Immunother. 2016 Sep;12(9):2475-7. doi: 10.1080/21645515.2016.1178433. Epub 2016 May 9. Hum Vaccin Immunother. 2016. PMID: 27159786 Free PMC article.

5

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries.

Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HE, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D. Kabakama S, et al. Among authors: gallagher ke. BMC Public Health. 2016 Aug 19;16(1):834. doi: 10.1186/s12889-016-3517-8. BMC Public Health. 2016. PMID: 27543037 Free PMC article.

6

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Griffiths UK, Feletto M, Burchett HED, LaMontagne DS, Watson-Jones D. Gallagher KE, et al. PLoS One. 2017 Jun 2;12(6):e0177773. doi: 10.1371/journal.pone.0177773. eCollection 2017. PLoS One. 2017. PMID: 28575074 Free PMC article.

7

What works for human papillomavirus vaccine introduction in low and middle-income countries?

Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, Watson-Jones D. Howard N, et al. Among authors: gallagher ke. Papillomavirus Res. 2017 Dec;4:22-25. doi: 10.1016/j.pvr.2017.06.003. Epub 2017 Jun 8. Papillomavirus Res. 2017. PMID: 29179865 Free PMC article. Review.

8

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.

Gallagher KE, Howard N, Kabakama S, Mounier-Jack S, Burchett HED, LaMontagne DS, Watson-Jones D. Gallagher KE, et al. Papillomavirus Res. 2017 Dec;4:72-78. doi: 10.1016/j.pvr.2017.09.001. Epub 2017 Oct 3. Papillomavirus Res. 2017. PMID: 29179873 Free PMC article.

9

The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.

Gallagher KE, Erio T, Baisley K, Lees S, Watson-Jones D. Gallagher KE, et al. BMC Health Serv Res. 2018 Mar 12;18(1):173. doi: 10.1186/s12913-018-2976-2. BMC Health Serv Res. 2018. PMID: 29530042 Free PMC article.

10

Status of HPV vaccine introduction and barriers to country uptake.

Gallagher KE, LaMontagne DS, Watson-Jones D. Gallagher KE, et al. Vaccine. 2018 Aug 6;36(32 Pt A):4761-4767. doi: 10.1016/j.vaccine.2018.02.003. Epub 2018 Mar 23. Vaccine. 2018. PMID: 29580641 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page